TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT04874194 — Predictive Biomarker (PRD): RUNX1 mRNA
Genes: RUNX1; AML1; CBFA2
Study NCT05918029 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04066751 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT04989322 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04989322 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04989322 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04989322 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT05202587 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06549777 — Predictive Biomarker (PRD): EDA mRNA
Genes: EDA; ED1; EDA2
Study NCT04973319 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05527483 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05299320 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05481502 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study NCT05317793 — Predictive Biomarker (PRD): EDA mRNA
Genes: EDA; ED1; EDA2
Study NCT05697588 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06629545 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06631404 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06629116 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05565456 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06628427 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study NCT06638931 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06632145 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04721106 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06630130 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06630130 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05640817 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05640817 — Safety Biomarker (SAF): Interleukin 1
Study NCT05640817 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT06630663 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06630663 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT06630663 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06519526 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT05430438 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05430438 — Surrogate Endpoint (SUR): Serum sodium
Study NCT06551727 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06631989 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06637345 — Predictive Biomarker (PRD): MTLN mRNA
Genes: MTLN; LEMP; LINC00116; MOXI; MPM; NCRNA00116; SMIM37
Study NCT06639009 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04254627 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05128903 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT05312541 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05968352 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05936437 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05487391 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05487391 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05309291 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study NCT06607770 — Predictive Biomarker (PRD): MIA mRNA
Genes: MIA
Study NCT06750549 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06499350 — Predictive Biomarker (PRD): AXL mRNA
Genes: AXL; UFO
Study NCT06146062 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04905407 — Predictive Biomarker (PRD): RARA mRNA
Genes: RARA; NR1B1
Study NCT03384537 — Surrogate Endpoint (SUR): Bacterial count
Study NCT04940676 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04940676 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study NCT05908760 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05169853 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06253650 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06659055 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05114109 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT06181383 — Predictive Biomarker (PRD): SV2A mRNA
Genes: SV2A; KIAA0736; PSEC0174
Study NCT05949957 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06197581 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06197581 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06641661 — Predictive Biomarker (PRD): NPC1L1 mRNA
Genes: NPC1L1
Study NCT06204796 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05302791 — Predictive Biomarker (PRD): TRIM63 mRNA
Genes: TRIM63; IRF; MURF1; RNF28; SMRZ
Study NCT05302791 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Growth/differentiation factor 8
Genes: MSTN; GDF8
Study NCT05302791 — Predictive Biomarker (PRD): MYF5 mRNA
Genes: MYF5; BHLHC2
Study NCT05302791 — Predictive Biomarker (PRD): MYF6 mRNA
Genes: MYF6; BHLHC4; MRF4
Study NCT05302791 — Predictive Biomarker (PRD): MYOD1 mRNA
Genes: MYOD1; BHLHC1; MYF3; MYOD
Study NCT05603676 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05200481 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04853576 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT05897775 — Predictive Biomarker (PRD): VIM mRNA
Genes: VIM
Study NCT04518930 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study NCT04518930 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT06639282 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06643143 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05176665 — Predictive Biomarker (PRD): EMB mRNA
Genes: EMB
Study NCT05727332 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04895566 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT04895566 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04779008 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04779008 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04779008 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT06660329 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05548296 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study NCT05216237 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04906343 — Predictive Biomarker (PRD): HGD mRNA
Genes: HGD; HGO
Study NCT05035173 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05035173 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05214573 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT06637150 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06643923 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05524012 — Predictive Biomarker (PRD): CCL20 mRNA
Genes: CCL20; LARC; MIP3A; SCYA20
Study NCT05524012 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT05185622 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT04467515 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06564324 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT06564324 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study NCT06253130 — Predictive Biomarker (PRD): PARP1 mRNA
Genes: PARP1; ADPRT; PPOL
Study NCT05618925 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06669702 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06669702 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06151483 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06701461 — Predictive Biomarker (PRD): EDA mRNA
Genes: EDA; ED1; EDA2
Study NCT06661213 — Predictive Biomarker (PRD): AHR mRNA
Genes: AHR; BHLHE76
Study NCT04856540 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study NCT05633927 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05633927 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05633927 — Predictive Biomarker (PRD): CD27 mRNA
Genes: CD27; TNFRSF7
Study NCT05633927 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05633927 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT05633927 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT05634174 — Predictive Biomarker (PRD): ADRB3 mRNA
Genes: ADRB3; ADRB3R; B3AR
Study NCT04531579 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT05797376 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05478837 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT05328765 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05704803 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05062525 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06259019 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CXCL1 mRNA
Genes: CXCL1; GRO; GRO1; GROA; MGSA; SCYB1
Study NCT00000821 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00000821 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03853304 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06493084 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT05545059 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06447103 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study NCT06456138 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05161481 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06628635 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06501196 — Predictive Biomarker (PRD): CLK1 mRNA
Genes: CLK1; CLK
Study NCT06278324 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05064085 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05064085 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04205786 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT04205786 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04205786 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05781451 — Predictive Biomarker (PRD): BTLA mRNA
Genes: BTLA
Study NCT05164653 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT06644443 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06644443 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study NCT04796025 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05946551 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05136495 — Predictive Biomarker (PRD): ADCY5 mRNA
Genes: ADCY5
Study NCT05781269 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05518045 — Predictive Biomarker (PRD): CCR8 mRNA
Genes: CCR8; CKRL1; CMKBR8; CMKBRL2
Study NCT05605197 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT05128747 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT06593951 — Predictive Biomarker (PRD): CSTB mRNA
Genes: CSTB; CST6; STFB
Study NCT06597656 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06674850 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06681766 — Monitoring Biomarker (MOI): Mitochondrial frataxin
Genes: FXN; FRDA; X25
Study NCT05039307 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05020457 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT05020457 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05020457 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04971122 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06172322 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05372367 — Safety Biomarker (SAF): SLCO1B1
Genes: OATP-C; LST-1; OATP1B1
Study NCT05372367 — Predictive Biomarker (PRD): SLCO1B3 mRNA
Genes: SLCO1B3; LST2; OATP1B3; OATP8; SLC21A8
Study NCT05372367 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05372367 — Predictive Biomarker (PRD): MDM2 mRNA
Genes: MDM2
Study NCT06327165 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05380700 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04783181 — Predictive Biomarker (PRD): CYP21A2 mRNA
Genes: CYP21A2; CYP21; CYP21B
Study NCT06377501 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05402891 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT05402891 — Predictive Biomarker (PRD): NOTUM mRNA
Genes: NOTUM; OK/SW-CL.30
Study NCT06309342 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05737784 — Predictive Biomarker (PRD): SCN2A mRNA
Genes: SCN2A; NAC2; SCN2A1; SCN2A2
Study NCT06628648 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06629194 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT06629909 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06629337 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06629337 — Predictive Biomarker (PRD): TPR mRNA
Genes: TPR
Study NCT06629337 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05605743 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04878042 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT05000450 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05395429 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study NCT04338165 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT04881799 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04881799 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05718817 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study NCT04638309 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT06564883 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06639685 — Predictive Biomarker (PRD): ASL mRNA
Genes: ASL
Study NCT04895007 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05888922 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06563986 — Predictive Biomarker (PRD): TPI1 mRNA
Genes: TPI1; TPI
Study NCT06507956 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06637267 — Predictive Biomarker (PRD): THBS1 mRNA
Genes: THBS1; TSP; TSP1
Study NCT06637267 — Predictive Biomarker (PRD): CTSD mRNA
Genes: CTSD; CPSD
Study NCT06642792 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT06639529 — Predictive Biomarker (PRD): CXCL3 mRNA
Genes: CXCL3; GRO3; GROG; SCYB3
Study NCT06645236 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05038839 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT04971733 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04518566 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study NCT06108947 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Placenta growth factor
Genes: PGF; PGFL; PLGF
Study NCT06185400 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06185400 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04165109 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04637061 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05896371 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05187650 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT06549231 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05050669 — Predictive Biomarker (PRD): ENPP1 mRNA
Genes: ENPP1; M6S1; NPPS; PC1; PDNP1
Study NCT05050669 — Predictive Biomarker (PRD): ABCC6 mRNA
Genes: ABCC6; ARA; MRP6
Study NCT05215652 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04124263 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04892277 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05585567 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05963984 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05963984 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05963984 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06564259 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study NCT04558736 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06608849 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06229990 — Predictive Biomarker (PRD): FST mRNA
Genes: FST
Study NCT06541197 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT06626516 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT06750926 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03645460 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT06315543 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04930432 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06255782 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study NCT06571864 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05704088 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06402305 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT05652530 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06528080 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06301022 — Surrogate Endpoint (SUR): Serum potassium
Study NCT06301022 — Safety Biomarker (SAF): Urinary total protein
Study NCT06638697 — Safety Biomarker (SAF): CREM mRNA
Genes: CREM
Study NCT04886531 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05562934 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05562934 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05473715 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05473715 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06173570 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06637657 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06263101 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT04621188 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT04621188 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04705766 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06563635 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05603637 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05745961 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT04998942 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06048042 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT05011383 — Predictive Biomarker (PRD): CHEK2 mRNA
Genes: CHEK2; CDS1; CHK2; RAD53
Study NCT04212923 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06570980 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04941885 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04941885 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05540483 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06565247 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06683846 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06683846 — Predictive Biomarker (PRD): TFE3 mRNA
Genes: TFE3; BHLHE33
Study NCT05083481 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06630767 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT04997161 — Surrogate Endpoint (SUR): Serum potassium
Study NCT06166719 — Surrogate Endpoint (SUR): Blood pressure